Prism Johnson (500338) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
21 Aug, 2026Executive summary
FY25 consolidated revenue declined by 4.8% YoY to ₹6,830 crore, with Cement and RMC segments down and HRJ (tiles and bathware) up 0.3%.
Consolidated revenue from operations for FY25 was ₹7,310.21 crore, slightly down from ₹7,426.60 crore in FY24.
EBITDA dropped 12.7% YoY to ₹456 crore, with margin contracting by 60 bps to 6.7% due to lower profitability in Cement; HRJ and RMC margins improved.
Net profit after tax and non-controlling interest for FY25 was ₹79.93 crore, compared to ₹181.11 crore in FY24.
Exceptional items, including a gain from the sale of industrial premises and various provisions, had a significant impact on results.
Financial highlights
Prism Cement revenue declined 8.9% YoY; RMC down 3.8% YoY; HRJ up 0.3% YoY.
Total income for FY25 was ₹7,438.38 crore, compared to ₹7,461.16 crore in FY24.
EBITDA and operating margins were pressured, with operating margin at 5.80% for FY25 versus 6.67% in FY24.
Net profit margin for FY25 was 0.63%, down from 2.21% in FY24.
EPS for FY25 was ₹1.59, compared to ₹3.60 in FY24.
Outlook and guidance
Management targets to regain past peak performance in the medium term, focusing on cost competitiveness, premium product mix, and capacity utilization.
Cement demand outlook remains strong, driven by housing and infrastructure; competition expected to intensify in Central India.
Management highlighted the impact of exceptional items and reclassification of insurance business items, noting that results are not strictly comparable year-over-year.
The acquisition of Sunbath Sanitary Private Limited is expected to contribute to future growth.
Latest events from Prism Johnson
- FY25 revenue reached ₹7,310 crore with strong cash flow and focus on sustainability and innovation.500338
Corporate presentation - Q1 FY25 revenue fell, EBITDA margin improved to 9.3%, but net loss reached ₹7.70 crore.500338
Q1 24/25 - Q2 FY25 saw a sharp YoY decline in revenue and margins, resulting in a significant net loss.500338
Q2 25/25 - Q3 FY25 revenue and net profit improved, but EBITDA and margins declined sharply.500338
Q3 24/25 - Revenue grew year-over-year, but profit declined amid margin pressures and arbitration.500338
Q1 25/26 - Quarterly profit returned with higher margins, led by cement and HRJ segment growth.500338
Q2 25/26 - Profitability and margins rose sharply, aided by asset sales despite labor code expenses.500338
Q3 25/26 - Revenue and EBITDA rose, but net profit was hit by exceptional items and insurance sale pending.500338
Q4 25/26 - Record EBITDA growth and profit surge driven by asset sales and insurance divestment.500338
Q1 26/27